Tirzepatide (75 mg)

What is Tirzepatide (75mg)?

Tirzepatide (75mg) is a synthetic investigational peptide used in laboratory research to study metabolic signaling pathways. It is designed to mimic incretin-related biological activity in experimental systems, particularly in relation to hormone signaling and nutrient regulation. Tirzepatide consists of 39 amino acids and has a molecular weight of 4,813.48 g/mol. Research-grade preparations are typically produced with ≥98% purity, verified through analytical testing. In controlled research environments, Tirzepatide is examined to understand its effects on glucose metabolism, energy balance, and hormone-mediated signaling. Due to its defined structure, it is frequently used as a molecular tool to study metabolic processes in preclinical studies.

What are the key features of Tirzepatide (75mg)?

Tirzepatide (75mg) is provided as a lyophilized powder for research use. The peptide is reconstituted by researchers for use in various controlled experimental protocols. Analytical testing ensures the peptide’s purity, identity, and consistency before it is distributed.

• Purity: Typically ≥98%, verified by HPLC analysis
• CAS Number: 2023788-19-2
• Chemical Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.48 g/mol
• Structure: Synthetic peptide composed of 39 amino acids
• Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys(C20-linker)-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂
• Format: 75 mg lyophilized powder in research vial
• Verification: Identity confirmed by mass spectrometry (MS)
• Research Classification: Investigated in metabolic and endocrine studies
• For laboratory research use only

How is Tirzepatide (75mg) synthesized?

Tirzepatide is synthesized using solid-phase peptide synthesis (SPPS), a method that ensures the accurate assembly of peptides with specific amino acid sequences. Protected amino acids are sequentially added to a resin support, which allows the controlled formation of the peptide chain. Once synthesis is complete, the peptide is purified through high-performance liquid chromatography (HPLC) to isolate the target peptide and remove impurities. Mass spectrometry (MS) is then used to confirm the peptide’s identity and molecular weight. After purification, the peptide is lyophilized into a stable powder for easy storage and reconstitution for research purposes.

What is Tirzepatide (75mg) being studied for? What are its possible benefits?

Tirzepatide has been the focus of research into metabolic and endocrine signaling. Due to its ability to mimic incretin hormones, it is studied for its effects on metabolic regulation and energy balance. Tirzepatide is being investigated in the following areas:

• Metabolic pathway signaling related to energy regulation
• Glucose metabolism processes in experimental models
• Hormone-mediated nutrient utilization
• Appetite-related signaling in laboratory models
• Body weight-related metabolic responses observed in preclinical studies

These studies help researchers understand how peptide-based signaling molecules influence complex metabolic systems.

How does Tirzepatide (75mg) work in research studies?

In research studies, Tirzepatide is analyzed for its impact on hormone-related signaling pathways that regulate metabolic processes. Researchers observe how the peptide interacts with cellular systems that control nutrient processing, energy balance, and glucose metabolism. Laboratory findings suggest that Tirzepatide may affect signaling networks involved in glucose regulation and metabolic communication between tissues. These studies help scientists understand how peptide hormones coordinate physiological responses to nutrient intake and energy demands. Tirzepatide is used as a research tool for studying these processes in controlled settings.

What dosing information exists for Tirzepatide (75mg)?

Dosing in research studies varies based on the experimental model used. In preclinical animal studies, Tirzepatide has been investigated at doses ranging from approximately 0.03 mg/kg to 10 mg/kg, administered per study protocols. In cell-based experiments, researchers typically test Tirzepatide at concentrations ranging from nanomolar to micromolar to observe its effects on cellular signaling. These concentrations are selected based on the specific goals of each experiment. It is important to note that there are no established dosing guidelines for human or veterinary use, as Tirzepatide in this format is intended exclusively for laboratory research.

How should Tirzepatide (75mg) be stored and handled?

To preserve peptide stability and ensure its integrity during research, proper storage is essential. Tirzepatide is provided as a lyophilized powder, which helps protect it from environmental degradation. Recommended storage practices:

• Store the lyophilized peptide at –20 °C or below for long-term stability
• Protect the vial from moisture, heat, and light exposure
• After reconstitution, solutions should be stored at 2–8 °C for short-term use
• Avoid repeated freeze-thaw cycles to minimize peptide degradation

Following these storage and handling practices ensures the peptide remains stable and maintains its purity throughout laboratory experiments.

Where can I read more research about Tirzepatide (50mg)?

1. National Center for Biotechnology Information. PubChem Compound Summary for CID 156588324, Tirzepatide. https://pubchem.ncbi.nlm.nih.gov/compound/156588324
2. Sun B, Willard FS, Feng D, et al. Structural determinants of dual incretin receptor agonism by tirzepatide. Proc Natl Acad Sci U S A. 2022;119(13):e2116506119. doi:10.1073/pnas.2116506119
3. Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018;18:3-14. doi:10.1016/j.molmet.2018.09.009
4. Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules. 2022;27(13):4315. Published 2022 Jul 5. doi:10.3390/molecules27134315
5. Tirzepatide: Uses, interactions, mechanism of action. DrugBank. https://go.drugbank.com/drugs/DB15171

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.